Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the free cash flow yield high or low?
The free cash flow yield of 4.79% is 14% below its 5-year average of 5.59%, near the low end of its 5-year range (4.32%–7.47%).
23.91% below its 12-month average of 6.29%.
Reported annual fiscal-period values; no daily interpolation.
FREE CASH FLOW YIELD
4.79%
FREE CASH FLOW YIELD AVG TTM
6.29%
FREE CASH FLOW YIELD AVG 3Y
6.06%
FREE CASH FLOW YIELD AVG 5Y
5.59%
FREE CASH FLOW YIELD AVG 10Y
5.96%
FREE CASH FLOW YIELD AVG 15Y
6.45%
FREE CASH FLOW YIELD AVG 20Y
6.18%
CURRENT VS TTM AVG
-23.91%
CURRENT VS 3Y AVG
-20.92%
CURRENT VS 5Y AVG
-14.34%
CURRENT VS 10Y AVG
-19.66%
CURRENT VS 15Y AVG
-25.72%
CURRENT VS 20Y AVG
-22.55%
SECTOR MEDIAN · HEALTHCARE
4.47%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
+7.16%
vs the sector median at left
Roche Holding AG
Market Cap
$351.81B
Free Cash Flow Yield
4.79%
TTM Avg
6.29%
3Y Avg
6.06%
5Y Avg
5.59%
Market Cap
$356.86B
Free Cash Flow Yield
6.60%
TTM Avg
6.18%
3Y Avg
5.28%
5Y Avg
5.29%
Market Cap
$366.18B
Free Cash Flow Yield
4.38%
TTM Avg
5.12%
3Y Avg
5.27%
5Y Avg
5.10%
Market Cap
$252.33B
Free Cash Flow Yield
3.44%
TTM Avg
3.14%
3Y Avg
3.22%
5Y Avg
3.03%
Market Cap
$451.38B
Free Cash Flow Yield
4.35%
TTM Avg
4.93%
3Y Avg
5.99%
5Y Avg
7.13%
Market Cap
$231.22B
Free Cash Flow Yield
3.13%
TTM Avg
3.24%
3Y Avg
3.44%
5Y Avg
3.30%
Market Cap
$202.54B
Free Cash Flow Yield
3.63%
TTM Avg
3.18%
3Y Avg
2.64%
5Y Avg
2.83%
Market Cap
$194.62B
Free Cash Flow Yield
4.45%
TTM Avg
3.82%
3Y Avg
3.15%
5Y Avg
3.54%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $351.81B | 4.79% | 6.29% | 6.06% | 5.59% |
| UnitedHealth Group Incorporated (UNH)vs › | $356.86B | 6.60% | 6.18% | 5.28% | 5.29% |
| Merck & Co., Inc. (MRK)vs › | $366.18B | 4.38% | 5.12% | 5.27% | 5.10% |
| AstraZeneca PLC (AZN)vs › | $252.33B | 3.44% | 3.14% | 3.22% | 3.03% |
| AbbVie Inc. (ABBV)vs › | $451.38B | 4.35% | 4.93% | 5.99% | 7.13% |
| Amgen Inc. (AMGN)vs › | $233.38B | 4.33% | 5.36% | 5.34% | 5.77% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $231.22B | 3.13% | 3.24% | 3.44% | 3.30% |
| Novo Nordisk A/S (NVO)vs › | $202.54B | 3.63% | 3.18% | 2.64% | 2.83% |
| Abbott Laboratories (ABT)vs › | $194.62B | 4.45% | 3.82% | 3.15% | 3.54% |
| Gilead Sciences, Inc. (GILD)vs › | $180.87B | 7.29% | 6.03% | 7.30% | 8.55% |
FCF Yield
4.79%
Earnings Yield
6.33%
Dividend Yield
2.81%
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2025-12-31 | 5.12% |
| 2024-12-31 | 7.47% |
| 2023-12-31 | 5.88% |
| 2022-12-31 | 5.76% |
| 2021-12-31 | 5.00% |
| 2020-12-31 | 4.32% |
| 2019-12-31 | 7.01% |
| 2018-12-31 | 7.63% |
| 2017-12-31 | 6.88% |
| 2016-12-31 | 5.49% |
| 2015-12-31 | 5.02% |
| 2014-12-31 | 5.65% |
| 2013-12-31 | 6.17% |
| 2012-12-31 | 8.18% |
| 2011-12-31 | 7.92% |
| 2010-12-31 | 9.68% |
| 2009-12-31 | 9.10% |
| 2008-12-31 | 6.11% |
| 2007-12-31 | 4.37% |
| 2006-12-31 | 3.33% |
| 2005-12-31 | 3.78% |
| 2004-12-31 | 4.30% |
| 2003-12-31 | 4.54% |
| 2002-12-31 | -2.38% |
| 2001-12-31 | 5.09% |
| 2000-12-31 | 1.86% |
| 1999-12-31 | -0.83% |
| 1998-12-31 | 1.05% |
